Can a second pill stop your migraine? new study investigates
NCT ID NCT07609914
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 6 times
Summary
This study looks at whether taking a second dose of the migraine medication rimegepant is safe and helpful for adults whose migraine pain isn't fully relieved by the first dose. About 400 people aged 18 and older with a history of migraines will take part. Researchers will track side effects and how satisfied participants are with their pain relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE TREATMENT OF MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brainstorm Research
RECRUITINGMiami, Florida, 33176, United States
-
Clinical Neuroscience Solutions
RECRUITINGOrlando, Florida, 32801, United States
-
FutureSearch Trials of Dallas
RECRUITINGDallas, Texas, 75251, United States
-
FutureSearch Trials of Neurology
NOT_YET_RECRUITINGAustin, Texas, 78731, United States
-
Headache Wellness Center
NOT_YET_RECRUITINGGreensboro, North Carolina, 27405, United States
-
Hope Clinical Research
RECRUITINGCanoga Park, California, 91303, United States
-
MedStar Health - Department of Neurology
NOT_YET_RECRUITINGMcLean, Virginia, 22101, United States
-
Michigan Headache & Neurological Institute
RECRUITINGAnn Arbor, Michigan, 48104, United States
-
Neurology Offices of South Florida
RECRUITINGBoca Raton, Florida, 33428, United States
-
New England Regional Headache Center
RECRUITINGWorcester, Massachusetts, 01609, United States
-
Proven Endpoints, LLC
NOT_YET_RECRUITINGRidgeland, Mississippi, 39157, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.